Skip to main content
Premium Trial:

Request an Annual Quote

No Genetic Discrimination Allowed ... Well, Except for Some of You

In the wake of GINA finally becoming law, Brandon Keim at Wired blogs about the "blind spots" the bill didn't deal with. He interviewed Tera Eerkes of Qtrait, who noted that some issues are still unresolved: for one, the law "does not prevent genetic discrimination against people when they are applying for life insurance, or long term care and disability insurance," she notes.

Another concern she has is that overcoming the GINA hurdle will "lead to a surge in demand for personal genetic testing" -- which is not necessarily a bad thing, as long as customers understand that they are often allowing the service companies to sell their genetic information to other organizations.

 

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.